Incredibly late thromboses in first generation drug eluting stents: a case series
- PMID: 20062627
- PMCID: PMC2803967
- DOI: 10.1186/1757-1626-2-9303
Incredibly late thromboses in first generation drug eluting stents: a case series
Abstract
Background: The drug-eluting stents have decreased the incidence of instent restenosis compared to bare metal stents. But, the incidence of late and very late stent thrombosis has increased with the drug-eluting stents.
Case presentation: We are here, reporting three cases of incredibly late instent thrombosis, each one occurring after more than 50 months of drug-eluting stent placement.
Conclusion: The occurrence of stent thrombosis as late as 5 years has been reported in literature. This highlights the importance that there may be no limit to the time duration to the occurrence of very late stent thrombosis and dual antiplatelet therapy with aspirin and clopidogrel may have to be continued indefinitely in patients with drug-eluting stents.
Figures






Similar articles
-
Drug-eluting stent thrombosis 1,659 days after stent deployment: case report and literature review.Tex Heart Inst J. 2010;37(3):343-6. Tex Heart Inst J. 2010. PMID: 20548819 Free PMC article. Review.
-
[Optimal platelet inhibition after coronary stent implantation. Current status].Herz. 2008 Jun;33(4):244-53. doi: 10.1007/s00059-008-3138-9. Herz. 2008. PMID: 18581073 Review. German.
-
Very late multivessel thrombosis of bare metal stents with concomitant patent drug-eluting stents after withdrawal of aspirin.Int J Cardiol. 2008 Dec 17;131(1):e7-9. doi: 10.1016/j.ijcard.2007.06.144. Epub 2007 Sep 19. Int J Cardiol. 2008. PMID: 17884201
-
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.JAMA. 2005 May 4;293(17):2126-30. doi: 10.1001/jama.293.17.2126. JAMA. 2005. PMID: 15870416
-
Is late stent thrombosis in drug-eluting stents a real clinical issue? A single-center experience and review of the literature.Clin Res Cardiol. 2007 Feb;96(2):86-93. doi: 10.1007/s00392-007-0464-x. Epub 2006 Dec 22. Clin Res Cardiol. 2007. PMID: 17180577 Review.
References
-
- Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344–2351. doi: 10.1161/CIRCULATIONAHA.106.685313. - DOI - PubMed
-
- Urban P, Gershlick AH, Guagliumi G, Guyon P, Lotan C, Schofer J, Seth A, Sousa JE, Wijns W, Berge C, Deme M, Stoll HP. Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation. 2006;113(11):1434–1441. doi: 10.1161/CIRCULATIONAHA.104.532242. - DOI - PubMed
-
- Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293(17):2126–2130. doi: 10.1001/jama.293.17.2126. - DOI - PubMed
LinkOut - more resources
Full Text Sources